Lupin Pharmaceuticals discontinued some quinapril tablets and recalled others in late December 2022, according to the American Society of Health-System Pharmacists. Pfizer and Solco Healthcare U.S. have their quinapril products on back order and allocation, respectively, and neither could estimate a resupply date.
Pfizer also reported a recall last April for 11 lots of its quinapril oral tablets, marketed as Accupril, but the drugmaker’s current shortage is because of a manufacturing delay, according to the ASHP.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
